ZA200004413B - Gelling ophthalmic compositions containing xanthan gum. - Google Patents

Gelling ophthalmic compositions containing xanthan gum.

Info

Publication number
ZA200004413B
ZA200004413B ZA200004413A ZA200004413A ZA200004413B ZA 200004413 B ZA200004413 B ZA 200004413B ZA 200004413 A ZA200004413 A ZA 200004413A ZA 200004413 A ZA200004413 A ZA 200004413A ZA 200004413 B ZA200004413 B ZA 200004413B
Authority
ZA
South Africa
Prior art keywords
compositions containing
xanthan gum
ophthalmic compositions
containing xanthan
gelling ophthalmic
Prior art date
Application number
ZA200004413A
Other languages
English (en)
Inventor
Rajan Bawa
Rex E Hall
Bhagwati P Kabra
James E Teague
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of ZA200004413B publication Critical patent/ZA200004413B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200004413A 1998-04-07 2000-08-25 Gelling ophthalmic compositions containing xanthan gum. ZA200004413B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8100498P 1998-04-07 1998-04-07

Publications (1)

Publication Number Publication Date
ZA200004413B true ZA200004413B (en) 2001-05-22

Family

ID=22161189

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200004413A ZA200004413B (en) 1998-04-07 2000-08-25 Gelling ophthalmic compositions containing xanthan gum.

Country Status (19)

Country Link
EP (1) EP1069913B1 (xx)
JP (1) JP4545927B2 (xx)
KR (1) KR100598722B1 (xx)
CN (1) CN1133466C (xx)
AR (1) AR016460A1 (xx)
AT (1) ATE245451T1 (xx)
AU (1) AU740586B2 (xx)
BR (1) BR9910113A (xx)
CA (1) CA2322579C (xx)
DE (1) DE69909768T2 (xx)
DK (1) DK1069913T3 (xx)
ES (1) ES2203103T3 (xx)
HK (1) HK1031335A1 (xx)
NZ (1) NZ506921A (xx)
PT (1) PT1069913E (xx)
TR (1) TR200002848T2 (xx)
TW (1) TWI262797B (xx)
WO (1) WO1999051273A1 (xx)
ZA (1) ZA200004413B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
DE20022450U1 (de) * 1999-01-19 2002-01-17 Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin Künstliche Tränenflüssigkeit in Gelform
WO2001032181A2 (en) 1999-11-01 2001-05-10 Alcon Universal Ltd. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
CA2395866C (en) * 2000-01-25 2009-10-13 Alcon, Inc. Ophthalmic anti-allergy compositions suitable for use with contact lenses
US6458836B1 (en) 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
HUP0300391A3 (en) * 2000-03-16 2008-05-28 Sucampo Ag Use of prostaglandin related compounds for preparation of composition for use in treatment of ocular hypertension and glaucoma
MXPA02012206A (es) 2000-07-14 2003-06-04 Allergan Inc Composiciones que contienen componentes terapeuticamente activos que tienen solubilidad mejorada.
CA2402405C (en) 2000-07-14 2008-02-12 Allergan Sales, Inc. Compositions containing alpha-2-adrenergic agonist components
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
ES2225573T3 (es) * 2000-07-28 2005-03-16 Alcon, Inc Composiciones farmaceuticas que contienen tobramicina y goma xantana.
WO2002040030A1 (en) * 2000-11-16 2002-05-23 Alcon Manufacturing, Ltd. Combination therapy for lowering and controlling intraocular pressure
US7084130B2 (en) 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
AU2002232437A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
WO2002049610A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
EP1343444B1 (en) * 2000-12-20 2013-09-25 Novartis AG Solution for removing cataracts via liquefracture
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
US7030149B2 (en) * 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
JP5222462B2 (ja) * 2003-08-21 2013-06-26 スキャンポ・アーゲー 眼科用組成物
JP4948176B2 (ja) 2004-09-28 2012-06-06 千寿製薬株式会社 キサンタンガムおよびアミノ酸を含有する眼科用組成物
WO2007032997A1 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation containing loteprednol etabonate for treatment of dry eye
US7875271B2 (en) 2006-03-23 2011-01-25 Senju Pharmaceutical Co., Ltd. Ophthalmic composition comprising xanthan gum and glucose
EP2050449A4 (en) 2006-07-31 2010-10-06 Senju Pharma Co AQUEOUS LIQUID PREPARATION CONTAINING AN AMIDE
BRPI0719776A2 (pt) * 2006-10-12 2014-04-22 Kyorin Seiyaku Kk Preparação líquida aquosa tendo penetração de gatifloxacino intraocular melhorada
TWI544934B (zh) * 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
CN102970973A (zh) * 2010-05-07 2013-03-13 太阳医药高级研发有限公司 新型眼用组合物
JP5713791B2 (ja) * 2010-05-12 2015-05-07 テイカ製薬株式会社 眼科用剤
KR20130094280A (ko) * 2010-06-23 2013-08-23 알콘 리서치, 리미티드 토브라마이신과 덱사메타손을 함유하는 국소 안과 현탁액
CN103079595B (zh) * 2010-08-27 2015-11-25 若素制药株式会社 滴眼用水性组合物
WO2016061147A1 (en) 2014-10-13 2016-04-21 John Eric Paderi Luminal vessel coating for arteriovenous fistula
WO2016061145A1 (en) 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
WO2016065083A1 (en) 2014-10-21 2016-04-28 Symic Biomedical, Inc. Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
CN104825386A (zh) * 2015-05-25 2015-08-12 湖北汇瑞药业股份有限公司 一种表皮麻醉凝胶及其制备方法
TW201718028A (zh) 2015-10-13 2017-06-01 賽米克Ｉｐ有限責任公司 Ve-鈣黏蛋白結合性生物結合物
KR101770324B1 (ko) 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
CN109722347B (zh) * 2019-01-03 2020-12-29 山东省药学科学院 一种含有黄原胶的保湿润滑组合物及其应用
KR102678138B1 (ko) * 2022-09-29 2024-06-25 주식회사태준제약 브리모니딘을 포함하는 안과용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4814160A (en) * 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
CA2231195C (en) * 1996-07-08 2003-01-21 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs

Also Published As

Publication number Publication date
PT1069913E (pt) 2003-11-28
CN1133466C (zh) 2004-01-07
BR9910113A (pt) 2000-12-26
CN1295483A (zh) 2001-05-16
DE69909768D1 (de) 2003-08-28
EP1069913A1 (en) 2001-01-24
JP2002510654A (ja) 2002-04-09
DE69909768T2 (de) 2004-06-17
AU740586B2 (en) 2001-11-08
CA2322579C (en) 2001-08-28
DK1069913T3 (da) 2003-11-17
EP1069913B1 (en) 2003-07-23
HK1031335A1 (en) 2001-06-15
KR20010041473A (ko) 2001-05-25
AU3194799A (en) 1999-10-25
TWI262797B (en) 2006-10-01
TR200002848T2 (tr) 2001-02-21
WO1999051273A1 (en) 1999-10-14
KR100598722B1 (ko) 2006-07-11
AR016460A1 (es) 2001-07-04
ES2203103T3 (es) 2004-04-01
NZ506921A (en) 2002-02-01
JP4545927B2 (ja) 2010-09-15
CA2322579A1 (en) 1999-10-14
ATE245451T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
ZA200004413B (en) Gelling ophthalmic compositions containing xanthan gum.
AU3100800A (en) Antimicrobial chewing gum
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
AU2001258801A1 (en) Gelling composition
AU2911399A (en) Natural substance based agent
AU2115301A (en) Dental compositions
ZA985553B (en) Filled polymer compositions.
AU5586800A (en) Low melt encapsulation
AU6795600A (en) Gums containing antimicrobial agents
AU2001279202A1 (en) Compositions containing phosphate and xanthan gum variants
HK1038884A1 (en) Medicinal compositions.
IL113657A0 (en) Pharmaceutical composition based on guar gum
AU1206901A (en) Composition for dentistry comprising an essential oil
ZA200108248B (en) Antiperspirant compositions.
HUP0102671A3 (en) Immunosupressive pharmaceutical compositions containing 2',2'-difluoro-nucleoside analogues
AU8053898A (en) Immunogenic compositions
HK1036974A1 (en) Indole derivatives and medicinal compositions containing the same.
AU3976800A (en) Antiperspirant compositions
ZA987797B (en) Oral compositions.
AU2422699A (en) Oral care compositions
AU5378599A (en) Oral formulation
AU3076600A (en) 3,7-disubstituted indole derivatives and medicinal compositions containing the same
HK1047114A1 (en) Streptogramin derivatives, production thereof and compositions containing the smae
AU4808499A (en) Gum base
AU4899797A (en) Chewing gum containing arabinogalactan